MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition.
The post MoonLake Immunotherapeutics explores sale appeared first on Reuters News Agency.
